Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Infinium Pharmachem's change in inventory for the quarter that ended in Mar. 2026 was ₹209 Mil. It means Infinium Pharmachem's inventory
declined by ₹209 Mil
from Sep. 2025 to Mar. 2026 .
Infinium Pharmachem's change in inventory for the fiscal year that ended in Mar. 2026 was ₹52 Mil. It means Infinium Pharmachem's inventory
declined by ₹52 Mil
from Mar. 2025 to Mar. 2026 .
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Infinium Pharmachem's Days Inventory for the quarter that ended in Mar. 2026 was 101.95.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Infinium Pharmachem's Inventory Turnover for the quarter that ended in Mar. 2026 was 1.79.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Infinium Pharmachem's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.48.
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Infinium Pharmachem's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Infinium Pharmachem Change In Inventory Related Terms
Infinium Pharmachem Change In Inventory Historical Data
* Premium members only.
The historical data trend for Infinium Pharmachem's Change In Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Infinium Pharmachem Change In Inventory Calculation
Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.
Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹52 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Infinium Pharmachem (NSE:INFINIUM) has a Change In Inventory of ₹52 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Infinium Pharmachem and its competitors.
Is Infinium Pharmachem's Change In Inventory too high?
Infinium Pharmachem's current Change In Inventory is ₹52 Mil. Overall, Infinium Pharmachem has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Infinium Pharmachem's Change In Inventory compare to DOW?
Infinium Pharmachem's Change In Inventory of ₹52 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Chemicals company?
A good Change In Inventory depends on the Chemicals industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Infinium Pharmachem and its competitors. Infinium Pharmachem's current Change In Inventory is ₹52 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Infinium Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Infinium Pharmachem (NSE:INFINIUM) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹312.56, compared to a current price of ₹265.00 — trading 15.2% below its estimated fair value. The current Change In Inventory is ₹52 Mil. Infinium Pharmachem's overall GF Score™ is 90/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Infinium Pharmachem (NSE:INFINIUM), the current Change In Inventory is ₹52 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Infinium Pharmachem (NSE:INFINIUM) Overvalued in 2026?
Based on GuruFocus' analysis, Infinium Pharmachem stock appears to be undervalued.
The current stock price of ₹265.00 is trading 15.2% below its estimated GF Value™ of ₹312.56.
GuruFocus considers Infinium Pharmachem to be Modestly Undervalued.
Key valuation signals for NSE:INFINIUM:
Change In Inventory: ₹52 Mil
GF Value™: ₹312.56 vs. price of ₹265.00 (15.2% below fair value)
No single metric tells the full story. See the NSE:INFINIUM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Infinium Pharmachem Ltd is engaged in the business of manufacturing and supplying Iodine, Iodine Derivatives and Active Pharmaceutical Ingredients (APIs). It provides fully integrated customized services from R & D to Commercial scale manufacturing and packaging for its products to the Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals and various other chemicals Industries.
90GF Score
Get the complete analysis for NSE:INFINIUM
Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INFINIUM has been successfully added to your 
